AbCellera Biologics Inc. ABCL Income taxes at U.S. statutory rate of 21%
Income taxes at U.S. statutory rate of 21% at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s income taxes at u.s. statutory rate of 21%.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s income taxes at U.S. statutory rate of 21%?
- AbCellera Biologics Inc. (ABCL) reported income taxes at U.S. statutory rate of 21% of 27% in Q4 2024.
- What does income taxes at U.S. statutory rate of 21% mean?
- This is the theoretical income tax expense calculated by applying the standard federal statutory tax rate to the company's pre-tax income or loss. It serves as the baseline for the effective tax rate reconciliation process. It allows investors to isolate the impact of specific tax planning strategies and permanent differences from the standard corporate tax burden.